Amedeo Smart

Free Medical Literature Service

 

Amedeo

Dermatology
  Free Subscription

25.10.2021

70 BMC Cancer
4 Cancer
3 Cancer Lett
3 Cutis
10 Int J Dermatol
2 Intern Med
3 N Engl J Med
2 Plast Reconstr Surg
3 PLoS Comput Biol
11 PLoS One
1 Proc Natl Acad Sci U S A


    BMC Cancer

  1. WANG B, Wang H, Zhao A, Zhang M, et al
    Poor prognosis of male triple-positive breast Cancer patients: a propensity score matched SEER analysis and molecular portraits.
    BMC Cancer. 2021;21:523.
    >> Share

  2. LIU Y, Teng L, Fu S, Wang G, et al
    Highly heterogeneous-related genes of triple-negative breast cancer: potential diagnostic and prognostic biomarkers.
    BMC Cancer. 2021;21:644.
    >> Share

  3. FOSTER M, Niedzwiedz CL
    Associations between multimorbidity and depression among breast cancer survivors within the UK Biobank cohort: a cross-sectional study.
    BMC Cancer. 2021;21:650.
    >> Share

  4. WANG D, Wei G, Ma J, Cheng S, et al
    Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients.
    BMC Cancer. 2021;21:645.
    >> Share

  5. HUANG S, Hu P, Lakowski TM
    Predicting breast cancer drug response using a multiple-layer cell line drug response network model.
    BMC Cancer. 2021;21:648.
    >> Share

  6. WOO J, Oh SJ, Song JY, Chae BJ, et al
    Response to neoadjuvant chemotherapy based on pathologic complete response in very young patients with ER-positive breast cancer: a large, multicenter, observational study.
    BMC Cancer. 2021;21:647.
    >> Share

  7. BORRERO-GARCIA LD, Del Mar Maldonado M, Medina-Velazquez J, Troche-Torres AL, et al
    Rac inhibition as a novel therapeutic strategy for EGFR/HER2 targeted therapy resistant breast cancer.
    BMC Cancer. 2021;21:652.
    >> Share

  8. KOTNIK U, Peterlin B, Lovrecic L
    Identification of women at risk for hereditary breast and ovarian cancer in a sample of 1000 Slovenian women: a comparison of guidelines.
    BMC Cancer. 2021;21:665.
    >> Share

  9. DHAKA B, Sabarinathan R
    Differential chromatin accessibility landscape of gain-of-function mutant p53 tumours.
    BMC Cancer. 2021;21:669.
    >> Share

  10. BREIDENBACH C, Wesselmann S, Sibert NT, Ortmann O, et al
    Use of social service counseling by cancer patients: an analysis of quality assurance data of 6339 breast cancer patients from 13 certified centers in Germany treated between 2015 and 2017.
    BMC Cancer. 2021;21:671.
    >> Share

  11. YU J, Lin C, Huang J, Hong J, et al
    Efficacy of adjuvant chemotherapy stratified by age and the 21-gene recurrence score in estrogen receptor-positive breast cancer.
    BMC Cancer. 2021;21:707.
    >> Share

  12. BAKOS B, Kiss A, Arvai K, Szili B, et al
    Co-occurrence of thyroid and breast cancer is associated with an increased oncogenic SNP burden.
    BMC Cancer. 2021;21:706.
    >> Share

  13. HALLER H, Voiss P, Cramer H, Paul A, et al
    The INTREST registry: protocol of a multicenter prospective cohort study of predictors of women's response to integrative breast cancer treatment.
    BMC Cancer. 2021;21:724.
    >> Share

  14. WANG K, Jin X, Wang W, Yu X, et al
    The role of postmastectomy radiation in patients with ypN0 breast cancer after neoadjuvant chemotherapy: a meta-analysis.
    BMC Cancer. 2021;21:728.
    >> Share

  15. YOO TK, Park SH, Do Han K, Chae BJ, et al
    Cardiovascular events and mortality in a population-based cohort initially diagnosed with ductal carcinoma in situ.
    BMC Cancer. 2021;21:735.
    >> Share

  16. HE C, Zhu WX, Tang Y, Bai Y, et al
    Knowledge of a cancer diagnosis is a protective factor for the survival of patients with breast cancer: a retrospective cohort study.
    BMC Cancer. 2021;21:739.
    >> Share

  17. MCWILLIAMS L, Woof VG, Donnelly LS, Howell A, et al
    Extending screening intervals for women at low risk of breast cancer: do they find it acceptable?
    BMC Cancer. 2021;21:637.
    >> Share

  18. ZHENG L, Zheng F, Xing Z, Zhang Y, et al
    Breast lesions excised via vacuum-assisted system: could we get any clues for B3 lesions before excision biopsy?
    BMC Cancer. 2021;21:633.
    >> Share

  19. CHOI SH, Yoon HS, Yoo SA, Yun SH, et al
    Co-relation with novel phosphorylation sites of IkappaBalpha and necroptosis in breast cancer cells.
    BMC Cancer. 2021;21:596.
    >> Share

  20. YANG JR, Kuo WL, Yu CC, Chen SC, et al
    Reconstructive outcome analysis of the impact of neoadjuvant chemotherapy on immediate breast reconstruction: a retrospective cross-sectional study.
    BMC Cancer. 2021;21:522.
    >> Share

  21. SOOD R, Masalu N, Connolly RM, Chao CA, et al
    Invasive breast Cancer treatment in Tanzania: landscape assessment to prepare for implementation of standardized treatment guidelines.
    BMC Cancer. 2021;21:527.
    >> Share

  22. ZHOU X, Zheng Z, Li Y, Zhao W, et al
    The clinical features and prognosis of patients with mucinous breast carcinoma compared with those with infiltrating ductal carcinoma: a population-based study.
    BMC Cancer. 2021;21:536.
    >> Share

  23. YANG S, Bian J, George TJ, Daily K, et al
    The association between cognitive impairment and breast and colorectal cancer screening utilization.
    BMC Cancer. 2021;21:539.
    >> Share

  24. WANG Y, Wang Y, Chen R, Tang Z, et al
    Plasma fibrinogen acts as a predictive factor for pathological complete response to neoadjuvant chemotherapy in breast cancer: a retrospective study of 1004 Chinese breast cancer patients.
    BMC Cancer. 2021;21:542.
    >> Share

  25. VALLECORSA P, Di Venosa G, Ballatore MB, Ferreyra D, et al
    Novel meso-substituted porphyrin derivatives and its potential use in photodynamic therapy of cancer.
    BMC Cancer. 2021;21:547.
    >> Share

  26. KOTANI H, Terada M, Mori M, Horisawa N, et al
    Compression therapy using surgical gloves does not prevent paclitaxel-induced peripheral neuropathy: results from a double-blind phase 2 trial.
    BMC Cancer. 2021;21:548.
    >> Share

  27. MILLS MN, Naz A, Thawani C, Walker C, et al
    Capecitabine and stereotactic radiation in the management of breast cancer brain metastases.
    BMC Cancer. 2021;21:552.
    >> Share

  28. NITTALA MR, Mundra EK, Packianathan S, Mehta D, et al
    The Will Rogers phenomenon, breast cancer and race.
    BMC Cancer. 2021;21:554.
    >> Share

  29. ZHANG M, Wang B, Liu N, Wang H, et al
    Nomogram for predicting preoperative regional lymph nodes metastasis in patients with metaplastic breast cancer: a SEER population-based study.
    BMC Cancer. 2021;21:565.
    >> Share

  30. CHAN CWH, Law BMH, Ng MSN, Wong CCY, et al
    Association of single nucleotide polymorphisms of cytochrome P450 enzymes with experience of vasomotor, vaginal and musculoskeletal symptoms among breast cancer patients: a systematic review.
    BMC Cancer. 2021;21:570.
    >> Share

  31. ZHANG Y, Asad S, Weber Z, Tallman D, et al
    Genomic features of rapid versus late relapse in triple negative breast cancer.
    BMC Cancer. 2021;21:568.
    >> Share

  32. ZOGRAFOS E, Korakiti AM, Andrikopoulou A, Rellias I, et al
    Germline mutations in a clinic-based series of pregnancy associated breast cancer patients.
    BMC Cancer. 2021;21:572.
    >> Share

  33. HAN P, Zhu J, Feng G, Wang Z, et al
    Characterization of alternative splicing events and prognostic signatures in breast cancer.
    BMC Cancer. 2021;21:587.
    >> Share

  34. ANWAR SL, Cahyono R, Prabowo D, Avanti WS, et al
    Metabolic comorbidities and the association with risks of recurrent metastatic disease in breast cancer survivors.
    BMC Cancer. 2021;21:590.
    >> Share

  35. VIALA M, Firmin N, Touraine C, Pouderoux S, et al
    Changes in vitamin D and calcium metabolism markers in patients undergoing adjuvant chemotherapy for breast cancer.
    BMC Cancer. 2021;21:815.
    >> Share

  36. LU H, Zha S, Zhang W, Wang Q, et al
    A systematic review and meta-analysis of nab-paclitaxel mono-chemotherapy for metastatic breast cancer.
    BMC Cancer. 2021;21:830.
    >> Share

  37. HACKSHAW MD, Danysh HE, Henderson M, Wang E, et al
    Prognostic factors of brain metastasis and survival among HER2-positive metastatic breast cancer patients: a systematic literature review.
    BMC Cancer. 2021;21:967.
    >> Share

  38. SZWIEC M, Tomiczek-Szwiec J, Kluzniak W, Wokolorczyk D, et al
    Genetic predisposition to male breast cancer in Poland.
    BMC Cancer. 2021;21:975.
    >> Share

  39. AMAYA C, Luo S, Baigorri J, Baucells R, et al
    Exposure to low intensity ultrasound removes paclitaxel cytotoxicity in breast and ovarian cancer cells.
    BMC Cancer. 2021;21:981.
    >> Share

  40. MARCELINO AC, Gozzi B, Cardoso-Filho C, Machado H, et al
    Race disparities in mortality by breast cancer from 2000 to 2017 in Sao Paulo, Brazil: a population-based retrospective study.
    BMC Cancer. 2021;21:998.
    >> Share

  41. FUKUI J, White K, Frankland TB, Oshiro C, et al
    Weight changes according to treatment in a diverse cohort of breast cancer patients.
    BMC Cancer. 2021;21:1005.
    >> Share

  42. LIU J, Yin J, Liu Y, Xu Z, et al
    Characteristics of 1270 Chinese sibling pairs with cancer.
    BMC Cancer. 2021;21:1027.
    >> Share

  43. ZHANG X, Pang X, Zhang Z, Liu Q, et al
    Co-expression and prognosis analyses of GLUT1-4 and RB1 in breast cancer.
    BMC Cancer. 2021;21:1026.
    >> Share

  44. JAKOBSEN M, Kolodziejczyk C, Jensen MS, Poulsen PB, et al
    Cardiovascular disease in women with breast cancer - a nationwide cohort study.
    BMC Cancer. 2021;21:1040.
    >> Share

  45. RAGALA MEA, El Hilaly J, Amaadour L, Omari M, et al
    Validation of Mini-Mental Adjustment to Cancer scale in a Moroccan sample of breast cancer women.
    BMC Cancer. 2021;21:1042.
    >> Share

  46. RODRIGUEZ-ACEVEDO AJ, Chan RJ, Olsen CM, Pandeya N, et al
    Out-of-pocket medical expenses compared across five years for patients with one of five common cancers in Australia.
    BMC Cancer. 2021;21:1055.
    >> Share

  47. AKINYEMIJU T, Jones K, Gupta A, Oyekunle T, et al
    Association of body composition with odds of breast cancer by molecular subtype: analysis of the Mechanisms for Established and Novel Risk Factors for Breast Cancer in Nigerian Women (MEND) study.
    BMC Cancer. 2021;21:1051.
    >> Share

  48. ABEBE E, Tollesa T, Assefa M, Tilahun Z, et al
    Cognitive functioning and its associated factors among breast cancer patients on chemotherapy at Tikur Anbessa specialized hospital, Addis Ababa Ethiopia: an institution-based comparative cross-sectional study.
    BMC Cancer. 2021;21:1052.
    >> Share

  49. LIN Y, Zhou X, Peng W, Wu J, et al
    Expression and clinical implications of basic leucine zipper ATF-like transcription factor 2 in breast cancer.
    BMC Cancer. 2021;21:1062.
    >> Share

  50. LEE J, Jung JH, Kim WW, Kang B, et al
    Short-term serial assessment of electronic patient-reported outcome for depression and anxiety in breast Cancer.
    BMC Cancer. 2021;21:1065.
    >> Share

  51. TSUKAMOTO F, Arihiro K, Takahashi M, Ito KI, et al
    Multicenter retrospective study on the use of Curebest 95GC Breast for estrogen receptor-positive and node-negative early breast cancer.
    BMC Cancer. 2021;21:1077.
    >> Share

  52. KIRKHAM AA, King K, Joy AA, Pelletier AB, et al
    Rationale and design of the Diet Restriction and Exercise-induced Adaptations in Metastatic breast cancer (DREAM) study: a 2-arm, parallel-group, phase II, randomized control trial of a short-term, calorie-restricted, and ketogenic diet plus exercise
    BMC Cancer. 2021;21:1093.
    >> Share

  53. LI Y, Ma L
    Nomograms predict survival of patients with lymph node-positive, luminal a breast cancer.
    BMC Cancer. 2021;21:965.
    >> Share

  54. DAI YH, Wang YF, Shen PC, Lo CH, et al
    Gene-associated methylation status of ST14 as a predictor of survival and hormone receptor positivity in breast Cancer.
    BMC Cancer. 2021;21:945.
    >> Share

  55. JANG MK, Han J, Kim SH, Ko YH, et al
    Comparison of fatigue and fatigability correlates in Korean breast cancer survivors and differences in associations with anxiety, depression, sleep disturbance, and endocrine symptoms: a randomized controlled trial.
    BMC Cancer. 2021;21:855.
    >> Share

  56. TURKISTANI S, Sugita BM, Fadda P, Marchi R, et al
    A panel of miRNAs as prognostic markers for African-American patients with triple negative breast cancer.
    BMC Cancer. 2021;21:861.
    >> Share

  57. WU W, Chen J, Deng H, Jin L, et al
    Neoadjuvant everolimus plus letrozole versus fluorouracil, epirubicin and cyclophosphamide for ER-positive, HER2-negative breast cancer: a randomized pilot trial.
    BMC Cancer. 2021;21:862.
    >> Share

  58. HAJJ A, Hachem R, Khoury R, Hallit S, et al
    Clinical and genetic factors associated with anxiety and depression in breast cancer patients: a cross-sectional study.
    BMC Cancer. 2021;21:872.
    >> Share

  59. WANG G, Zhang S, Wang M, Liu L, et al
    Prognostic significance of occult lymph node metastases in breast cancer: a meta-analysis.
    BMC Cancer. 2021;21:875.
    >> Share

  60. WANG Y, Men X, Gu Y, Wang H, et al
    Haplotype analysis on correlation between transcription factor 7-like 2 gene polymorphism and breast cancer risk.
    BMC Cancer. 2021;21:885.
    >> Share

  61. CHAN RJ, Cooper B, Gordon L, Hart N, et al
    Distinct employment interference profiles in patients with breast cancer prior to and for 12 months following surgery.
    BMC Cancer. 2021;21:883.
    >> Share

  62. ALGEO N, Bennett K, Connolly D
    Rehabilitation interventions to support return to work for women with breast cancer: a systematic review and meta-analysis.
    BMC Cancer. 2021;21:895.
    >> Share

  63. TAVARES MC, Sampaio CD, Lima GE, Andrade VP, et al
    A high CD8 to FOXP3 ratio in the tumor stroma and expression of PTEN in tumor cells are associated with improved survival in non-metastatic triple-negative breast carcinoma.
    BMC Cancer. 2021;21:901.
    >> Share

  64. MOON SY, Lee H, Kim S, Hong JH, et al
    Inhibition of STAT3 enhances sensitivity to tamoxifen in tamoxifen-resistant breast cancer cells.
    BMC Cancer. 2021;21:931.
    >> Share

  65. STURKEN C, Mobus V, Milde-Langosch K, Schmatloch S, et al
    TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer.
    BMC Cancer. 2021;21:920.
    >> Share

  66. ZHANG Y, Zhang D, Meng Q, Liu Z, et al
    Precision treatment exploration of breast cancer based on heterogeneity analysis of lncRNAs at the single-cell level.
    BMC Cancer. 2021;21:918.
    >> Share

  67. SU TP, Huang JS, Chang PH, Lui KW, et al
    Prospective comparison of early interim (18)F-FDG-PET with (18)F-FLT-PET for predicting treatment response and survival in metastatic breast cancer.
    BMC Cancer. 2021;21:908.
    >> Share

  68. ZOU MH, Huang Q, Yang T, Jiang Y, et al
    Role of ultrasound in the diagnosis of primary and recurrent dermatofibrosarcoma protuberans.
    BMC Cancer. 2021;21:909.
    >> Share

  69. DE CALUWE A, Buisseret L, Poortmans P, Van Gestel D, et al
    Neo-CheckRay: radiation therapy and adenosine pathway blockade to increase benefit of immuno-chemotherapy in early stage luminal B breast cancer, a randomized phase II trial.
    BMC Cancer. 2021;21:899.
    >> Share

  70. CHEBET JJ, Ehiri JE, McClelland DJ, Taren D, et al
    Effect of d-limonene and its derivatives on breast cancer in human trials: a scoping review and narrative synthesis.
    BMC Cancer. 2021;21:902.
    >> Share


    Cancer

  71. CHU QD, Li T, Hsieh MC, Yi Y, et al
    Positive impact of the Patient Protection and Affordable Care Act Medicaid expansion on Louisiana women with breast cancer.
    Cancer. 2020 Nov 3. doi: 10.1002/cncr.33265.
    >> Share

  72. FAYANJU OM, Ren Y, Stashko I, Power S, et al
    Patient-reported causes of distress predict disparities in time to evaluation and time to treatment after breast cancer diagnosis.
    Cancer. 2020 Nov 11. doi: 10.1002/cncr.33310.
    >> Share

  73. LEONE JP, Cole BF, Regan MM, Thurlimann B, et al
    Clinical behavior of recurrent hormone receptor-positive breast cancer by adjuvant endocrine therapy within the Breast International Group 1-98 clinical trial.
    Cancer. 2020 Dec 8. doi: 10.1002/cncr.33318.
    >> Share

  74. ZHAO F, Henderson TO, Cipriano TM, Copley BL, et al
    The impact of coronavirus disease 2019 on the quality of life and treatment disruption of patients with breast cancer in a multiethnic cohort.
    Cancer. 2021 Jul 22. doi: 10.1002/cncr.33798.
    >> Share


    Cancer Lett

  75. VENKATESH J, Wasson MD, Brown JM, Fernando W, et al
    LncRNA-miRNA axes in breast cancer: Novel points of interaction for strategic attack.
    Cancer Lett. 2021 Apr 10. pii: S0304-3835(21)00156.
    >> Share

  76. WANG CJ, Li D, Danielson JA, Zhang EH, et al
    Proton pump inhibitors suppress DNA damage repair and sensitize treatment resistance in breast cancer by targeting fatty acid synthase.
    Cancer Lett. 2021 Apr 1. pii: S0304-3835(21)00149.
    >> Share

  77. KAUL K, Misri S, Ramaswamy B, Ganju RK, et al
    Contribution of the tumor and obese microenvironment to triple negative breast cancer.
    Cancer Lett. 2021 Mar 30. pii: S0304-3835(21)00141.
    >> Share


    Cutis

  78. CHAT VS, Uppal SK, Kearns DG, Han G, et al
    Translating the 2019 AAD-NPF Guidelines of Care for Psoriasis With Attention to Comorbidities.
    Cutis. 2021;108.
    >> Share

  79. IVANIC MG, Ahn GS, Herndon P, Wu JJ, et al
    Update on Biologics for Psoriasis in Clinical Practice.
    Cutis. 2021;108.
    >> Share

  80. JOHNSON MC, Oussedik E, Huang WW, Kammrath LK, et al
    Anecdote Increases Patient Willingness to Take a Biologic Medication for Psoriasis.
    Cutis. 2021;108.
    >> Share


    Int J Dermatol

  81. KARVAR M, Panayi AC, Alavi A, Baziar Z, et al
    Trends in the management of hidradenitis suppurativa in the Middle East region: a systematic review.
    Int J Dermatol. 2021;60:e440-e448.
    >> Share

  82. OLVERA-RODRIGUEZ V, Gatica-Torres M, Carrillo-Cordova DM, Barrera-Godinez A, et al
    Painful nails: A practical approach to the diagnosis and management of painful nail conditions.
    Int J Dermatol. 2021;60:1318-1333.
    >> Share

  83. PREDA-NAUMESCU A, Ahmed HN, Mayo TT, Yusuf N, et al
    Hidradenitis suppurativa: pathogenesis, clinical presentation, epidemiology, and comorbid associations.
    Int J Dermatol. 2021;60:e449-e458.
    >> Share

  84. HINES A, Hazim A, Wetter DA, Bridges AG, et al
    Retrospective analysis of 578 inpatient dermatology consultations in hematology and hematopoietic stem cell transplant patients.
    Int J Dermatol. 2021;60:1385-1391.
    >> Share

  85. DI BRIZZI EV, Pampena R, Licata G, Calabrese G, et al
    Are we born and do we die without nevi? A cross-sectional study.
    Int J Dermatol. 2021;60:1405-1410.
    >> Share

  86. OMAR SI, Hamza AM, Eldabah N, Habiba DA, et al
    IFN-alpha and TNF-alpha serum levels and their association with disease severity in Egyptian children and adults with alopecia areata.
    Int J Dermatol. 2021;60:1397-1404.
    >> Share

  87. KIM HT, Choi ME, Na H, Lee WJ, et al
    Partial unilateral lentiginosis: a clinicopathological analysis of 32 cases on the head and neck area in Korea.
    Int J Dermatol. 2021;60:1376-1384.
    >> Share

  88. GOTESMAN RD, Choi C, Alavi A
    Hidradenitis suppurativa in East and Southeast Asian populations: a systematic review and meta-analysis.
    Int J Dermatol. 2021;60:e433-e439.
    >> Share

  89. SACHDEVA M, Mufti A, Zaaroura H, Abduelmula A, et al
    Squamous cell carcinoma arising within hidradenitis suppurativa: a literature review.
    Int J Dermatol. 2021;60:e459-e465.
    >> Share

  90. SANTOS TS, Hernandez Galvis K, Vano Galvan S, Saceda-Corralo D, et al
    Post-chemotherapy alopecia: what the dermatologist needs to know.
    Int J Dermatol. 2021;60:1313-1317.
    >> Share


    Intern Med

  91. HIRAOKA A, Onishi M, Koyama S, Kato M, et al
    Factors Related to Sleeping Disorder Due to Pruritus in Patients with Chronic Liver Disease.
    Intern Med. 2021;60:3195-3203.
    >> Share

  92. YAGI S, Takahashi T, Murakami K, Azuma M, et al
    Infective Endocarditis from Furuncle with Meningitis Complication Caused by Methicillin-resistant Staphylococcus aureus.
    Intern Med. 2021;60:3251-3255.
    >> Share


    N Engl J Med

  93. NOZAWA K, Yoshimura A, Iwata H
    Adjuvant Olaparib in BRCA-Mutated Breast Cancer.
    N Engl J Med. 2021;385:1439.
    >> Share

  94. HOSHI A, Bando H, Sekine I
    Adjuvant Olaparib in BRCA-Mutated Breast Cancer.
    N Engl J Med. 2021;385:1439-1440.
    >> Share

  95. TUTT ANJ, Garber JE, Geyer CE Jr
    Adjuvant Olaparib in BRCA-Mutated Breast Cancer. Reply.
    N Engl J Med. 2021;385:1440.
    >> Share


    Plast Reconstr Surg

  96. LEE E, Sacks JM
    Reply: Public Perceptions on Breast Implant-Associated Anaplastic Large Cell Lymphoma.
    Plast Reconstr Surg. 2021;148:300e-301e.
    >> Share

  97. GULIYEVA G, Huayllani MT, Avila FR, Torres RA, et al
    Public Perceptions on Breast Implant-Associated Anaplastic Large Cell Lymphoma.
    Plast Reconstr Surg. 2021;148:299e-300e.
    >> Share


    PLoS Comput Biol

  98. DEUTSCH A, Nava-Sedeno JM, Syga S, Hatzikirou H, et al
    BIO-LGCA: A cellular automaton modelling class for analysing collective cell migration.
    PLoS Comput Biol. 2021;17:e1009066.
    >> Share

  99. LAL A, Liu K, Tibshirani R, Sidow A, et al
    De novo mutational signature discovery in tumor genomes using SparseSignatures.
    PLoS Comput Biol. 2021;17:e1009119.
    >> Share

  100. ERDEM C, Lee AV, Taylor DL, Lezon TR, et al
    Inhibition of RPS6K reveals context-dependent Akt activity in luminal breast cancer cells.
    PLoS Comput Biol. 2021;17:e1009125.
    >> Share


    PLoS One

  101. BLASI MA, Maceroni M, Caputo CG, Sammarco MG, et al
    Clinical and ultrasonographic features of choroidal metastases based on primary cancer site: Long-term experience in a single center.
    PLoS One. 2021;16:e0249210.
    >> Share

  102. KOOP Y, Dobbe L, Maas AHEM, van Spronsen DJ, et al
    Oncology professionals' perspectives towards cardiac surveillance in breast cancer patients with high cardiotoxicity risk: A qualitative study.
    PLoS One. 2021;16:e0249067.
    >> Share

  103. BAMOROVAT M, Sharifi I, Rashedi E, Shafiian A, et al
    A novel diagnostic and prognostic approach for unresponsive patients with anthroponotic cutaneous leishmaniasis using artificial neural networks.
    PLoS One. 2021;16:e0250904.
    >> Share

  104. ELOBAID Y, Aamir M, Grivna M, Suliman A, et al
    Breast cancer survival and its prognostic factors in the United Arab Emirates: A retrospective study.
    PLoS One. 2021;16:e0251118.
    >> Share

  105. ZOELLER JJ, Press MF, Selfors LM, Dering J, et al
    Clinical evaluation of BCL-2/XL levels pre- and post- HER2-targeted therapy.
    PLoS One. 2021;16:e0251163.
    >> Share

  106. COUPS EJ, Xu B, Heckman CJ, Manne SL, et al
    Physician skin cancer screening among U.S. military veterans: Results from the National Health Interview Survey.
    PLoS One. 2021;16:e0251785.
    >> Share

  107. LEE SB, Kim H, Kim J, Chung IY, et al
    Prognosis according to clinical and pathologic lymph node status in breast cancer patients who underwent sentinel lymph node biopsy alone after neoadjuvant therapy.
    PLoS One. 2021;16:e0251597.
    >> Share

  108. SOLDATI E, Escoffier L, Gabriel S, Ogier AC, et al
    Assessment of in vivo bone microarchitecture changes in an anti-TNFalpha treated psoriatic arthritic patient.
    PLoS One. 2021;16:e0251788.
    >> Share

  109. STONE JK, Vukadin L, Ahn EE
    eNEMAL, an enhancer RNA transcribed from a distal MALAT1 enhancer, promotes NEAT1 long isoform expression.
    PLoS One. 2021;16:e0251515.
    >> Share

  110. SANDERS MGH, Nijsten T, Verlouw J, Kraaij R, et al
    Composition of cutaneous bacterial microbiome in seborrheic dermatitis patients: A cross-sectional study.
    PLoS One. 2021;16:e0251136.
    >> Share

  111. NG DY, Tudor Car L, Ng MJM, Lu J, et al
    Identifying barriers to early presentation in patients with locally advanced breast cancer (LABC) in Northern Singapore: Qualitative study.
    PLoS One. 2021;16:e0252008.
    >> Share


    Proc Natl Acad Sci U S A

  112. VOISIN T, Perner C, Messou MA, Shiers S, et al
    The CysLT2R receptor mediates leukotriene C4-driven acute and chronic itch.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016